D. Gordon, J. Probstfield, R. Garrison, J. Neaton, W. Castelli et al., High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies, Circulation, vol.79, issue.1, pp.8-15, 1989.
DOI : 10.1161/01.CIR.79.1.8

P. Barter, A. Gotto, J. Larosa, J. Maroni, M. Szarek et al., HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events, New England Journal of Medicine, vol.357, issue.13, pp.1301-1311, 2007.
DOI : 10.1056/NEJMoa064278

D. Angelantonio, E. Sarwar, N. Perry, P. Kaptoge, S. Ray et al., Major lipids, apolipoproteins, and risk of vascular disease, JAMA, vol.302, pp.1993-2000, 2009.

M. Chapman, H. Ginsberg, P. Amarenco, F. Andreotti, J. Borén et al., Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management, European Heart Journal, vol.32, issue.11, pp.1345-61, 2011.
DOI : 10.1093/eurheartj/ehr112

W. Boden, J. Probstfield, T. Anderson, B. Chaitman, P. Desvignes-nickens et al., Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy, N Engl J Med, vol.365, pp.2255-67, 2011.

P. Barter, M. Caulfield, M. Eriksson, S. Grundy, J. Kastelein et al., Effects of Torcetrapib in Patients at High Risk for Coronary Events, New England Journal of Medicine, vol.357, issue.21, pp.2109-2131, 2007.
DOI : 10.1056/NEJMoa0706628

H. Mundl, S. Nicholls, P. Shah, J. Tardif, and R. Wright, Effects of dalcetrapib in patients with a recent acute coronary syndrome, N Engl J Med, vol.367, pp.2089-99, 2012.

B. Voight, G. Peloso, M. Orho-melander, R. Frikke-schmidt, M. Barbalic et al., Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study, The Lancet, vol.380, issue.9841, pp.572-80, 2012.
DOI : 10.1016/S0140-6736(12)60312-2

M. Haghpassand, P. Bourassa, O. Francone, and R. Aiello, Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels, Journal of Clinical Investigation, vol.108, issue.9, pp.1315-1335, 2001.
DOI : 10.1172/JCI200112810

E. Degoma, R. Degoma, and D. Rader, Beyond High-Density Lipoprotein Cholesterol Levels, Journal of the American College of Cardiology, vol.51, issue.23, pp.2199-211, 2008.
DOI : 10.1016/j.jacc.2008.03.016

C. Santos-gallego, HDL: Quality or quantity?, Atherosclerosis, vol.243, issue.1, pp.121-124, 2015.
DOI : 10.1016/j.atherosclerosis.2015.08.027

L. Martinez, S. Jacquet, J. Esteve, C. Rolland, E. Cabezon et al., Ectopic ??-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis, Nature, vol.269, issue.6918, pp.75-84, 2003.
DOI : 10.1074/jbc.M204996200

C. Radojkovic, A. Genoux, V. Pons, G. Combes, H. De-jonge et al., Stimulation of Cell Surface F1-ATPase Activity by Apolipoprotein A-I Inhibits Endothelial Cell Apoptosis and Promotes Proliferation, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.7, pp.1125-1155, 2009.
DOI : 10.1161/ATVBAHA.109.187997

C. Cavelier, P. Ohnsorg, L. Rohrer, and A. Von-eckardstein, The ??-Chain of Cell Surface F0F1 ATPase Modulates ApoA-I and HDL Transcytosis Through Aortic Endothelial Cells, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.1, pp.131-140, 2012.
DOI : 10.1161/ATVBAHA.111.238063

L. Martinez, S. Najib, B. Perret, C. Cabou, and L. Lichtenstein, Ecto-F1-ATPase/P2Y pathways in metabolic and vascular functions of high density lipoproteins, Atherosclerosis, vol.238, issue.1, pp.89-100, 2015.
DOI : 10.1016/j.atherosclerosis.2014.11.017

A. Genoux, V. Pons, C. Radojkovic, F. Roux-dalvai, G. Combes et al., Mitochondrial Inhibitory Factor 1 (IF1) Is Present in Human Serum and Is Positively Correlated with HDL-Cholesterol, PLoS ONE, vol.581, issue.9, p.23949, 2011.
DOI : 10.1371/journal.pone.0023949.t001

A. Genoux, J. Ruidavets, J. Ferrières, G. Combes, L. Lichtenstein et al., Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study, The Journal of Lipid Research, vol.54, issue.9, pp.2550-2558, 2013.
DOI : 10.1194/jlr.P036335
URL : https://hal.archives-ouvertes.fr/inserm-01055265

S. Hascoet, M. Elbaz, V. Bongard, F. Bouisset, C. Verdier et al., Adiponectin and Long-Term Mortality in Coronary Artery Disease Participants and Controls, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.33, issue.1, pp.19-29, 2013.
DOI : 10.1161/ATVBAHA.112.300079

J. Roeykens, R. Rogers, R. Meeusen, L. Magnus, J. Borms et al., Validity and reliability in a Flemish population of the WHO-MONICA Optional Study of Physical Activity Questionnaire, Medicine & Science in Sports & Exercise, vol.30, issue.7, pp.1071-1076, 1998.
DOI : 10.1097/00005768-199807000-00008

H. Resnick, R. Lindsay, M. Mcdermott, R. Devereux, K. Jones et al., Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study, Circulation, vol.109, issue.6, pp.733-742, 2004.
DOI : 10.1161/01.CIR.0000112642.63927.54

G. Gensini, A more meaningful scoring system for determining the severity of coronary heart disease, The American Journal of Cardiology, vol.51, issue.3, p.606, 1983.
DOI : 10.1016/S0002-9149(83)80105-2

R. Califf, H. Phillips, M. Hindman, D. Mark, K. Lee et al., Prognostic value of a coronary artery jeopardy score, Journal of the American College of Cardiology, vol.5, issue.5, pp.1055-63, 1985.
DOI : 10.1016/S0735-1097(85)80005-X

P. Ducimetiere, L. Guize, A. Marciniak, H. Milon, J. Richard et al., Arteriographically documented coronary artery disease and alcohol consumption in French men. The CORALI Study, European Heart Journal, vol.14, issue.6, pp.727-760, 1993.
DOI : 10.1093/eurheartj/14.6.727

E. Harchaoui, K. Arsenault, B. Franssen, R. Després, J. Hovingh et al., High-Density Lipoprotein Particle Size and Concentration and Coronary Risk, Annals of Internal Medicine, vol.150, issue.2, pp.84-93, 2009.
DOI : 10.7326/0003-4819-150-2-200901200-00006

C. Ditah, J. Otvos, H. Nassar, D. Shaham, R. Sinnreich et al., Small and medium sized HDL particles are protectively associated with coronary calcification in a cross-sectional population-based sample, Atherosclerosis, vol.251, pp.124-155, 2016.
DOI : 10.1016/j.atherosclerosis.2016.06.010

E. Angeloni, F. Paneni, U. Landmesser, U. Benedetto, G. Melina et al., Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting, European Heart Journal, vol.34, issue.46, pp.3557-62, 2013.
DOI : 10.1093/eurheartj/eht163

G. Silbernagel, B. Schöttker, S. Appelbaum, H. Scharnagl, M. Kleber et al., High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality, European Heart Journal, vol.34, issue.46, pp.3563-71, 2013.
DOI : 10.1093/eurheartj/eht343

T. Lüscher, U. Landmesser, A. Von-eckardstein, and A. Fogelman, High-Density Lipoprotein, Circulation Research, vol.114, issue.1, pp.171-82, 2014.
DOI : 10.1161/CIRCRESAHA.114.300935

L. Sánchez-cenizo, L. Formentini, M. Aldea, A. Ortega, P. García-huerta et al., Up-regulation of the ATPase Inhibitory Factor 1 (IF1) of the Mitochondrial H+-ATP Synthase in Human Tumors Mediates the Metabolic Shift of Cancer Cells to a Warburg Phenotype, Journal of Biological Chemistry, vol.285, issue.33, pp.25308-25321, 2010.
DOI : 10.1074/jbc.M110.146480

M. Sánchez-aragó, L. Formentini, I. Martínez-reyes, J. García-bermudez, F. Santacatterina et al., Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers, Oncogenesis, vol.2, issue.4, p.46, 2012.
DOI : 10.1042/BJ20111829

S. Zhong, D. Sharp, J. Grove, C. Bruce, K. Yano et al., Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels., Journal of Clinical Investigation, vol.97, issue.12, pp.2917-2940, 1996.
DOI : 10.1172/JCI118751

P. Cortes-hernandez, L. Dominguez-ramirez, A. Estrada-bernal, D. Montes-sanchez, A. Zentella-dehesa et al., The inhibitor protein of the F1F0-ATP synthase is associated to the external surface of endothelial cells, Biochemical and Biophysical Research Communications, vol.330, issue.3, pp.844-853, 2005.
DOI : 10.1016/j.bbrc.2005.03.064

S. Contessi, M. Comelli, S. Cmet, G. Lippe, and I. Mavelli, IF1 distribution in HepG2 cells in relation to ecto???F0F1ATPsynthase and calmodulin, Journal of Bioenergetics and Biomembranes, vol.274, issue.2, pp.291-300, 2007.
DOI : 10.1007/s10863-007-9091-0

V. Giorgio, E. Bisetto, R. Franca, D. Harris, S. Passamonti et al., The ectopic FOF1 ATP synthase of rat liver is modulated in acute cholestasis by the inhibitor protein IF1, Journal of Bioenergetics and Biomembranes, vol.49, issue.2, pp.117-140, 2010.
DOI : 10.1007/s10863-010-9270-2

A. Fabre, C. Malaval, B. Addi, A. Verdier, C. Pons et al., P2Y13 receptor is critical for reverse cholesterol transport, Hepatology, vol.44, issue.4, pp.1477-83, 2010.
DOI : 10.1002/hep.23897

L. Huang, I. Chuang, H. Dong, and R. Yang, Hypoxia-Inducible Factor 1?? Regulates the Expression of the Mitochondrial ATPase Inhibitor Protein (IF1) in Rat Liver, Shock, vol.36, issue.1, pp.90-96, 2011.
DOI : 10.1097/SHK.0b013e318219ff2a

J. Afilalo, A. Majdan, and M. Eisenberg, Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials, Heart, vol.93, issue.8, pp.914-935, 2007.
DOI : 10.1136/hrt.2006.112508

F. Angeli, G. Reboldi, M. Garofoli, E. Ramundo, and P. Verdecchia, Very early initiation of statin therapy and mortality in patients with acute coronary syndrome, Acute Cardiac Care, vol.103, issue.1, pp.34-43, 2012.
DOI : 10.1080/10623320303359

V. Bataille, B. Perret, A. Evans, P. Amouyel, D. Arveiler et al., Sex hormone-binding globulin is a major determinant of the lipid profile: the PRIME study, Atherosclerosis, vol.179, issue.2, pp.369-73, 2005.
DOI : 10.1016/j.atherosclerosis.2004.10.029

Y. Qi, J. Fan, J. Liu, W. Wang, M. Wang et al., Cholesterol-Overloaded HDL Particles Are Independently Associated With Progression of Carotid Atherosclerosis in a Cardiovascular Disease-Free Population, Journal of the American College of Cardiology, vol.65, issue.4, pp.355-63, 2015.
DOI : 10.1016/j.jacc.2014.11.019

C. Gebhard, D. Rhainds, and J. Tardif, HDL and cardiovascular risk: is cholesterol in particle subclasses relevant?, European Heart Journal, vol.36, issue.1, pp.10-12, 2015.
DOI : 10.1093/eurheartj/ehu306

D. Saleheen, R. Scott, S. Javad, W. Zhao, A. Rodrigues et al., Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study, The Lancet Diabetes & Endocrinology, vol.3, issue.7, pp.507-520, 2015.
DOI : 10.1016/S2213-8587(15)00126-6